Pacira Biosciences Inc
XBER:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
XBER:82P
|
US |
|
C
|
Citizens Financial Group Inc
LSE:0HYP
|
US |
|
U
|
UniCredit SpA
BMV:UCGN
|
IT |
|
D
|
DiDi Global Inc
OTC:DIDIY
|
CN |
|
P
|
Philippine Metals Inc
F:PM7A
|
CA |
|
Danaher Corp
NYSE:DHR
|
US |
|
Daetwyler Holding AG
SIX:DAE
|
CH |
|
EQTEC PLC
LSE:EQT
|
IE |
|
T
|
Tessenderlo Group NV
SWB:TEZ
|
BE |
|
I
|
Ibiden Co Ltd
OTC:IBIDF
|
JP |
|
Saudi Telecom Company SJSC
SAU:7010
|
SA |
|
M
|
Macy's Inc
XMUN:FDO
|
US |
|
Banco Bradesco SA
BOVESPA:BBDC4
|
BR |
|
Unicharm Corp
F:UN41
|
JP |
|
C
|
China Pacific Insurance Group Co Ltd
OTC:CHPXF
|
CN |
|
L
|
Lotte Rental Co Ltd
KRX:089860
|
KR |
|
Zai Lab Ltd
HKEX:9688
|
CN |
|
Heidelberger Beteiligungsholding AG
F:IPOK
|
DE |
|
P
|
Petroleo Brasileiro SA Petrobras
MAD:XPBRA
|
BR |
|
E
|
EDP Energias de Portugal SA
ELI:EDP
|
PT |
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
C
|
Compass Group PLC
SWB:XGR2
|
UK |
|
Glencore PLC
LSE:0IVW
|
CH |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 37.28 EUR with a low forecast of 29.42 EUR and a high forecast of 50.53 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
37.28
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 37.28 EUR with a low forecast of 29.42 EUR and a high forecast of 50.53 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
110%
The compound annual growth rate for Operating Income over the next 3 years is 110%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
224%
The compound annual growth rate for Net Income over the next 3 years is 224%.
